Oxford Lymphoid Disorders Study Group
The Oxford Lymphoid Disorders Study Group (OLDSG) was launched in September 2020, and brings together a network of researchers and clinicians from across the University of Oxford and Oxford University Hospitals Trust.
At present, around 3-4% of people will develop either lymphoma or Chronic Lymphocytic Leukaemia (CLL) during their lifetime. Together, lymphoma and CLL represent the commonest blood cancer by some margin.
The purpose of OLDSG is to:
- to increase the visibility of lymphoid disorder research in the university
- to foster collaborations between clinicians and laboratory-based scientists leading to high quality translational projects
- to interact with patients and the public at all levels of project development to deliver research which impacts directly on patient need
Group members work on a range of issues relating to lymphoid disorders, haematology, immunology, molecular diagnostics and late effects research.
BLOOD CANCER NEWS
7 October 2021
The 'What Matters Most’ initiative was designed as a way of bringing people with Myelodyspastic Syndrome together to talk about their shared experience, and agree a list of priorities for research and service / resource development.
1 October 2021
A new study published this week in Nature, provides the most detailed analysis so far of the prenatal development of blood and immune cells in the bone marrow.